Anna Vähärautio
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 2
- Endometriosis Research and Treatment 2
- Obstetrics and Gynecology top 5%
- Uterine Myomas and Treatments 2
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
- Molecular Biology top 10%
- Single-cell and spatial transcriptomics 7
- Genomics and Chromatin Dynamics 3
- DNA Repair Mechanisms 2
- CRISPR and Genetic Engineering 2
- Co-authors
- Jussi TaipaleMartin EngeTeemu KiviojaMartin BonkeKasper KarlssonSten LinnarssonLauri A. AaltonenMikko Turunen
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Anna Vähärautio
18 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Reproductive Medicine 224
- Obstetrics and Gynecology 197
- Cancer Research 368
- Molecular Biology 950
- Immunology 191
Countries citing papers authored by Anna Vähärautio
This map shows the geographic impact of Anna Vähärautio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vähärautio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vähärautio more than expected).
Fields of papers citing papers by Anna Vähärautio
This network shows the impact of papers produced by Anna Vähärautio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vähärautio. The network helps show where Anna Vähärautio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Vähärautio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 13 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 7 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 93 | |
| 9 | 2021 | 45 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 11 | |
| 12 | 2018 | 76 | |
| 13 | 2016 | 157 | |
| 14 | 2016 | 19 | |
| 15 | 2014 | 123 | |
| 16 | 2013 | 20 | |
| 17 | 2012 | 149 | |
| 18 | Counting absolute numbers of molecules using unique molecular identifiersbreakdown → | 2011 | 707 |
About Anna Vähärautio
Anna Vähärautio is a scholar working on Cancer Research, Reproductive Medicine and Obstetrics and Gynecology, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (7 papers), Cancer Genomics and Diagnostics (7 papers), Genomics and Chromatin Dynamics (3 papers), DNA Repair Mechanisms (2 papers), Ovarian cancer diagnosis and treatment (2 papers), CRISPR and Genetic Engineering (2 papers), Uterine Myomas and Treatments (2 papers) and Endometriosis Research and Treatment (2 papers). The work is most often cited by research in Reproductive Medicine (224 citations), Obstetrics and Gynecology (197 citations) and Cancer Research (368 citations). Anna Vähärautio has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Jussi Taipale, Martin Enge, Teemu Kivioja, Martin Bonke, Kasper Karlsson, Sten Linnarsson, Lauri A. Aaltonen, Mikko Turunen, Minna Taipale and Pia Vahteristo. Their work appears in journals such as Nature Communications, Nature Methods, Scientific Reports, Clinical Cancer Research and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.